Sacral Transcutaneous Electrical Stimulation Efficacy in Chronic Pelvic Pain: A Randomized Clinical Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chronic Pelvic Pain Syndrome
- Sponsor
- Istanbul University
- Enrollment
- 38
- Locations
- 1
- Primary Endpoint
- Visual Numeric Scale of Pain
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this interventional study is to test of efficacy of sacral Transcutaneous Electrical Stimulation (TENS) in patients with chronic pelvic pain.
The main questions it aims to answer are:
- Is sacral transcutaneous electrical stimulation (TENS) effective to reduce/relief pain in patients with chronic pelvic pain?
- Is the effect of TENS comparable to sham stimulation therapy in patients with chronic pelvic pain?
Detailed Description
Our study aiming to test the efficacy of sacral transcutaneous electrical stimulation (TENS) intervention in patients with chronic pelvic pain. We aim to test the efficacy and compare it with sham stimulation therapy in chronic pelvic pain.
Investigators
Nalan Capan Bolukbas
Associate Professor
Istanbul University
Eligibility Criteria
Inclusion Criteria
- •Female with chronic pelvic pain for ≥6 months
- •18-65 years old
- •Visual Numeric Scale of Pain score ≥4/10
- •Voluntarily participate to the study
Exclusion Criteria
- •Pregnancy
- •Having severe medical and/or psychiatric disorder
- •Malignancy
- •Chronic infection
- •Inflammatory musculoskeletal system disease
- •Skin infection in sacral/pelvic area
- •Having implanted neuromodulatory device (such as pacemaker or defibrillator)
- •Refusing to participate the study
Outcomes
Primary Outcomes
Visual Numeric Scale of Pain
Time Frame: Baseline (Before Treatment), immediately After Treatment and 1 Month After Treatment
Patients with Chronic Pelvic Pain assessed their pain levels before, right after and 1 month after treatment
Secondary Outcomes
- The Pelvic Pain Impact Questionnaire(Baseline (Before Treatment), immediately After Treatment and 1 Month After Treatment)
- Female Sexual Function Index(Baseline (Before Treatment), immediately After Treatment and 1 Month After Treatment)
- Patient Satisfaction Questionnaire(Immediately After Treatment and 1 Month After Treatment)